Our team includes pioneers in genome editing and leaders in cell and gene therapy who are committed to solving significant medical problems. LeadershipBoard of Directors Michael AmorosoPresident, Chief Executive Officer Derek Jantz, Ph.D.Chief Scientific Officer & Strategy Jeff Smith, Ph.D.Chief Research Officer Cindy AtwellChief Business Officer Juli BlancheChief People Officer Alex KellyChief Financial Officer Alan List, M.D.Chief Medical Officer Dario ScimecaGeneral Counsel Kevin Buehler Michael AmorosoPresident, Chief Executive Officer Melinda Brown Stanley Frankel, M.D. Geno Germano Shari Lisa Piré, J.D. Sam Wadsworth, Ph.D.
